Hydroxycarbamide Oral Solution Stability via pH and Xanthan Gum

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing oral solutions of hydroxycarbamide suffer from instability and short shelf-life, particularly when stored at higher temperatures, leading to the formation of unknown degradation impurities.

Innovation Solution

An oral pharmaceutical solution comprising hydroxycarbamide with a pharmaceutically acceptable aqueous carrier, including a buffer and xanthan gum, is formulated to maintain a pH between 3.0 and 6.0, significantly enhancing the stability and shelf-life of the solution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If hydroxycarbamide is formulated in an aqueous oral solution with pH adjusted to 6.5-6.7, then the solution maintains stability at refrigeration temperatures, but the solution forms unknown degradation impurities when stored at higher temperatures and has limited shelf-life

Engineering Contradiction:
Improvestability of hydroxycarbamide solutionVSAvoidformation of degradation impurities
Core Design Contradiction:
Stability of the object's compositionVSObject-affected harmful factors

Solution Approach 1:

The patent applies parameter changes by adjusting the pH of the aqueous solution to a lower range of 5.0-6.0 and optimizing the concentration of xanthan gum to 0.5-2.4 mg/ml. This modification of chemical parameters prevents the formation of degradation impurities while maintaining solution stability, resolving the contradiction between stability and impurity formation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Xanthan gum is introduced as an intermediary stabilizing agent in the solution. It acts as a protective mediator that prevents degradation of hydroxycarbamide by maintaining the structural integrity of the solution and preventing molecular interactions that lead to impurity formation, thereby eliminating the harmful degradation effect.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Stability of the object's composition

If hydroxycarbamide oral solution is stored at refrigeration temperatures (2°C to 8°C), then the solution remains stable, but the solution requires continuous refrigeration and cannot be stored at higher temperatures

Engineering Contradiction:
Improvestability of hydroxycarbamide solutionVSAvoidstorage temperature range
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameters of the solution by adjusting pH to 5.0-6.0 and optimizing xanthan gum concentration, which fundamentally alters the stability profile of hydroxycarbamide. This enables the solution to maintain stability across a broader temperature range including room temperature, thereby increasing storage adaptability without sacrificing stability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces the requirement for continuous refrigeration (an expensive and logistically complex storage condition) with a chemically stabilized formulation that can be stored at ambient temperatures. This makes the product more accessible and easier to distribute, especially in resource-limited settings.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If the pH of the hydroxycarbamide solution is adjusted to 6.6, then the solution appears stable initially, but the amount of unknown impurity increases significantly with time especially when stored at 25°C/60% RH

Engineering Contradiction:
Improveinitial stability of solutionVSAvoidshelf-life of solution
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent identifies that pH 6.6, while providing initial stability, leads to progressive degradation over time. By changing the pH parameter to the optimized range of 5.0-6.0 and combining it with optimized xanthan gum concentration, the formulation achieves both initial stability and long-term durability, extending the shelf-life significantly.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention incorporates stability feedback by monitoring the behavior of hydroxycarbamide at different pH levels and storage conditions. This feedback information is used to optimize the formulation parameters, ensuring that the solution maintains its stability profile throughout the intended shelf-life under various storage conditions.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution exhibits excellent physicochemical stability at room temperature and refrigeration conditions, eliminating the unknown degradation impurity at RRT 0.44 and maintaining stability for at least one month at 25°C/60% RH and nine months at 2°C - 8°C.

Implementation Method 1

a pharmaceutically acceptable buffer... wherein the pH of the solution is from 3.0 to 6.0

Methodology Applied
Scientific EffectBuffering action:

Implementation Method 2

0.5 mg/ml to 2.4 mg/ml xanthan gum

Methodology Applied
Scientific EffectViscosifying action:

Data Source

PatentEP4494633A1Hydroxycarbamide containing oral solution
Publication Date: 2025.01.22 A FINE HOUSE SA
  • EP4494633A1 patent drawing
  • EP4494633A1 patent drawing
  • EP4494633A1 patent drawing

AI summary

An oral pharmaceutical solution comprising hydroxycarbamide as active ingredient and an aqueous carrier comprising a pharmaceutically acceptable buffer and 0.5 mg/ml to 2.4 mg/ml xanthan gum, wherein the pH of the solution is from 3.0 to 6.0.